Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Carré M, Porcher R, Finke J, Ehninger G, Koster L, Beelen D, Ganser A, Volin L, Lozano S, Friis L, Michallet M, Tischer J, Olavarria E, Cascon MJP, Iacobelli S, Koc Y, Jindra P, Arat M, de Witte T, Yakoub Agha I, Kröger N, Robin M. Carré M, et al. Among authors: friis l. Biol Blood Marrow Transplant. 2020 Mar;26(3):451-457. doi: 10.1016/j.bbmt.2019.10.015. Epub 2019 Oct 21. Biol Blood Marrow Transplant. 2020. PMID: 31647984 Free article.
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT.
Koenecke C, Eikema DJ, Hazelaar S, Schroeder T, Potter V, Kröger N, Bornhäuser M, Finke J, Platzbecker U, Radujkovic A, Ganser A, Salmenniem U, Blaise D, Kobbe G, Meijer E, Friis L, Maertens J, Caballero D, Cornelissen JJ, Olivieri A, Gulsum O, Hayden PJ, Onida F, Robin M, Yakoub-Agha I. Koenecke C, et al. Among authors: friis l. Bone Marrow Transplant. 2022 Oct;57(10):1607-1611. doi: 10.1038/s41409-022-01759-7. Epub 2022 Jul 23. Bone Marrow Transplant. 2022. PMID: 35871086 Free PMC article. No abstract available.
Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation.
Gagelmann N, Eikema DJ, Stelljes M, Beelen D, de Wreede L, Mufti G, Knelange NS, Niederwieser D, Friis LS, Ehninger G, Nagler A, Yakoub-Agha I, Meijer E, Ljungman P, Maertens J, Kanz L, Lopez-Corral L, Brecht A, Craddock C, Finke J, Cornelissen JJ, Bernasconi P, Chevallier P, Sierra J, Robin M, Kröger N. Gagelmann N, et al. Among authors: friis ls. Haematologica. 2019 May;104(5):929-936. doi: 10.3324/haematol.2018.200808. Epub 2019 Jan 17. Haematologica. 2019. PMID: 30655377 Free PMC article.
C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation.
Minculescu L, Kornblit BT, Friis LS, Schiødt I, Petersen SL, Andersen NS, Sengeloev H. Minculescu L, et al. Among authors: friis ls. Biol Blood Marrow Transplant. 2018 Mar;24(3):600-607. doi: 10.1016/j.bbmt.2017.10.025. Epub 2017 Oct 23. Biol Blood Marrow Transplant. 2018. PMID: 29074374 Free article. Clinical Trial.
Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Gjærde LK, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Ostrowski SR, Sengeløv H. Gjærde LK, et al. Among authors: friis ls. Bone Marrow Transplant. 2020 Jul;55(7):1457-1459. doi: 10.1038/s41409-019-0760-5. Epub 2019 Nov 26. Bone Marrow Transplant. 2020. PMID: 31772337 No abstract available.
A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients.
Burnett AK, Russell NH, Hills RK, Kell J, Cavenagh J, Kjeldsen L, McMullin MF, Cahalin P, Dennis M, Friis L, Thomas IF, Milligan D, Clark RE; UK NCRI AML Study Group. Burnett AK, et al. Among authors: friis l. Blood. 2015 Jun 18;125(25):3878-85. doi: 10.1182/blood-2015-01-623447. Epub 2015 Apr 1. Blood. 2015. PMID: 25833957 Free PMC article. Clinical Trial.
Trends in survival and cure after allogeneic haematopoietic cell transplantation for acute myeloid leukaemia from 2000 to 2020: A Danish population-based cohort study.
Gjaerde LK, Jakobsen LH, Juhl-Christensen C, Olesen G, Petruskevicius I, Severinsen MT, Marcher CW, Theilgaard-Mönch K, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H. Gjaerde LK, et al. Among authors: friis ls. Br J Haematol. 2023 Feb;200(4):e40-e43. doi: 10.1111/bjh.18511. Epub 2022 Oct 20. Br J Haematol. 2023. PMID: 36263998 No abstract available.
Addressing the room for improvement in management of acute promyelocytic leukemia.
Nørgaard JM, Friis LS, Kristensen JS, Severinsen MT, Mølle I, Marcher CW, Møller P, Schoellkopf C, Nielsen OJ, Preiss BS, Andersen MK, Kjeldsen E, Medeiros BC, Østgård LSG; Danish Acute Leukemia Group. Nørgaard JM, et al. Eur J Haematol. 2019 Jun;102(6):479-485. doi: 10.1111/ejh.13229. Epub 2019 Apr 7. Eur J Haematol. 2019. PMID: 30887583
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK, Russell NH, Hills RK, Bowen D, Kell J, Knapper S, Morgan YG, Lok J, Grech A, Jones G, Khwaja A, Friis L, McMullin MF, Hunter A, Clark RE, Grimwade D; UK National Cancer Research Institute Acute Myeloid Leukaemia Working Group. Burnett AK, et al. Among authors: friis l. Lancet Oncol. 2015 Oct;16(13):1295-305. doi: 10.1016/S1470-2045(15)00193-X. Epub 2015 Sep 14. Lancet Oncol. 2015. PMID: 26384238 Clinical Trial.
93 results